The Scientist

» patent and microbiology

Most Recent

image: Students Study Their Own Microbiomes

Students Study Their Own Microbiomes

By | June 1, 2016

Pooping into a petri dish is becoming standard practice as part of some college biology courses.

0 Comments

image: Gut Bacteria for Insect RNAi

Gut Bacteria for Insect RNAi

By | June 1, 2016

Lacing insect food with microbes encoding double-stranded RNAs can suppress insect gene expression.

0 Comments

image: Antibiotic Affects Cow Dung

Antibiotic Affects Cow Dung

By | May 25, 2016

Researchers assess some of the downstream effects of treating livestock with a broad-spectrum antibiotic.

3 Comments

Post-publication peer review prompts the authors to clarify the ages of mice used in their experiments and share additional data.

0 Comments

image: Narrow-Spectrum Antibiotic Could Spare the Microbiome

Narrow-Spectrum Antibiotic Could Spare the Microbiome

By | May 9, 2016

A drug that singles out Staphylococcus aureus leaves gut-dwelling microbiota largely intact, a mouse study shows.

0 Comments

image: Most Gut Microbes Can Be Cultured

Most Gut Microbes Can Be Cultured

By | May 4, 2016

Contrary to the popular thought that many species are “unculturable,” the majority of bacteria known to populate the human gut can be grown in the lab, scientists show.

0 Comments

image: Earth: Home to 1 Trillion Microbial Species

Earth: Home to 1 Trillion Microbial Species

By | May 4, 2016

A new analysis of microbial data estimates that the world is home to 1 trillion species—of which only 0.001 percent have been discovered.

0 Comments

image: Becoming Acculturated

Becoming Acculturated

By | May 1, 2016

Techniques for deep dives into the microbial dark matter

0 Comments

image: Microbial Ice-Makers

Microbial Ice-Makers

By | April 26, 2016

How one bacterium turns water into ice at nonfreezing temperatures

4 Comments

image: Another Gene-Editing IPO

Another Gene-Editing IPO

By | April 12, 2016

Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.

0 Comments

Popular Now

  1. Infant Microbiome: Vaginal Delivery Versus C-Section
  2. Immune System Maintains Brain Health
  3. Opinion: WHO’s Silence on Cannabis
  4. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

Rockland